[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Polypeptide Drug Market Research Report Forecast 2017-2022

April 2017 | 104 pages | ID: CEB65FD503FEN
S&P Consulting

US$ 2,480.00 US$ 3,100.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Delivery of the Report will take 2-3 working days once order is placed.

The China Polypeptide Drug Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Polypeptide Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Polypeptide Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:

Novartis
Merck Serono
Ferring Pharmaceuticals
Ipsen PHarma Biotech
Lilly
Asahi Kasei
AstraZeneca
SciClone Pharmaceuticals
Takeda

China Polypeptide Drug Market: Product Segment Analysis
  • Type 1
  • Type 2
  • Type 3
China Polypeptide Drug Market: Application Segment Analysis
  • Application 1
  • Application 2
  • Application 3
Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 POLYPEPTIDE DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Polypeptide Drug
1.2 Polypeptide Drug Market Segmentation by Type
  1.2.1 China Production Market Share of Polypeptide Drug by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Polypeptide Drug Market Segmentation by Application
  1.3.1 Polypeptide Drug Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Polypeptide Drug (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON POLYPEPTIDE DRUG INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Polypeptide Drug Industry

CHAPTER 3 CHINA POLYPEPTIDE DRUG MARKET COMPETITION BY MANUFACTURERS

3.1 China Polypeptide Drug Production and Share by Manufacturers (2015 and 2016)
3.2 China Polypeptide Drug Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Polypeptide Drug Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Polypeptide Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Polypeptide Drug Market Competitive Situation and Trends
  3.5.1 Polypeptide Drug Market Concentration Rate
  3.5.2 Polypeptide Drug Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA POLYPEPTIDE DRUG CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Polypeptide Drug Capacity, Production and Growth (2012-2017)
4.2 China Polypeptide Drug Revenue and Growth (2012-2017)
4.3 China Polypeptide Drug Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA POLYPEPTIDE DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Polypeptide Drug Production and Market Share by Type (2012-2017)
5.2 China Polypeptide Drug Revenue and Market Share by Type (2012-2017)
5.3 China Polypeptide Drug Price by Type (2012-2017)
5.4 China Polypeptide Drug Production Growth by Type (2012-2017)

CHAPTER 6 CHINA POLYPEPTIDE DRUG MARKET ANALYSIS BY APPLICATION

6.1 China Polypeptide Drug Consumption and Market Share by Application (2012-2017)
6.2 China Polypeptide Drug Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA POLYPEPTIDE DRUG MANUFACTURERS ANALYSIS

7.1 Novartis
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 Merck Serono
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 Ferring Pharmaceuticals
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 Ipsen PHarma Biotech
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 Lilly
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 Asahi Kasei
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 AstraZeneca
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 SciClone Pharmaceuticals
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 Takeda
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 POLYPEPTIDE DRUG MANUFACTURING COST ANALYSIS

8.1 Polypeptide Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Polypeptide Drug

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Polypeptide Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2016
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA POLYPEPTIDE DRUG MARKET FORECAST (2017-2022)

12.1 China Polypeptide Drug Production, Revenue Forecast (2017-2022)
12.2 China Polypeptide Drug Production, Consumption Forecast by Regions (2017-2022)
12.3 China Polypeptide Drug Production Forecast by Type (2017-2022)
12.4 China Polypeptide Drug Consumption Forecast by Application (2017-2022)
12.5 Polypeptide Drug Price Forecast (2017-2022)

CHAPTER 13 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Polypeptide Drug
Figure China Production Market Share of Polypeptide Drug by Type in 2016
Table Polypeptide Drug Consumption Market Share by Application in 2016
Figure China Polypeptide Drug Revenue (Million USD) and Growth Rate (2012-2021)
Table China Polypeptide Drug Capacity of Key Manufacturers (2015 and 2016)
Table China Polypeptide Drug Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Polypeptide Drug Capacity of Key Manufacturers in 2015
Figure China Polypeptide Drug Capacity of Key Manufacturers in 2016
Table China Polypeptide Drug Production of Key Manufacturers (2015 and 2016)
Table China Polypeptide Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Polypeptide Drug Production Share by Manufacturers
Figure 2016 Polypeptide Drug Production Share by Manufacturers
Table China Polypeptide Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Polypeptide Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Polypeptide Drug Revenue Share by Manufacturers
Table 2016 China Polypeptide Drug Revenue Share by Manufacturers
Table China Market Polypeptide Drug Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Polypeptide Drug Average Price of Key Manufacturers in 2016
Table Manufacturers Polypeptide Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Polypeptide Drug Product Type
Figure Polypeptide Drug Market Share of Top 3 Manufacturers
Figure Polypeptide Drug Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Polypeptide Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Polypeptide Drug Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Polypeptide Drug Market Share (2012-2017)
Table Merck Serono Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck Serono Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck Serono Polypeptide Drug Market Share (2012-2017)
Table Ferring Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Ferring Pharmaceuticals Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Ferring Pharmaceuticals Polypeptide Drug Market Share (2012-2017)
Table Ipsen PHarma Biotech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Ipsen PHarma Biotech Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Ipsen PHarma Biotech Polypeptide Drug Market Share (2012-2017)
Table Lilly Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Lilly Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Lilly Polypeptide Drug Market Share (2012-2017)
Table Asahi Kasei Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Asahi Kasei Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Asahi Kasei Polypeptide Drug Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Polypeptide Drug Market Share (2012-2017)
Table SciClone Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table SciClone Pharmaceuticals Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table SciClone Pharmaceuticals Polypeptide Drug Market Share (2012-2017)
Table Takeda Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Takeda Polypeptide Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Takeda Polypeptide Drug Market Share (2012-2017)
Figure Production Revenue Share of Polypeptide Drug by Type (2012-2017)
Figure 2015 Revenue Market Share of Polypeptide Drug by Type
Table China Polypeptide Drug Price by Type (2012-2017)
Figure China Polypeptide Drug Production Growth by Type (2012-2017)
Table China Polypeptide Drug Consumption by Application (2012-2017)
Table China Polypeptide Drug Consumption Market Share by Application (2012-2017)
Figure China Polypeptide Drug Consumption Market Share by Application in 2016
Table China Polypeptide Drug Consumption Growth Rate by Application (2012-2017)
Figure China Polypeptide Drug Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Polypeptide Drug
Figure Manufacturing Process Analysis of Polypeptide Drug
Figure Polypeptide Drug Industrial Chain Analysis
Table Raw Materials Sources of Polypeptide Drug Major Manufacturers in 2015
Table Major Buyers of Polypeptide Drug
Table Distributors/Traders List
Figure China Polypeptide Drug Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Polypeptide Drug Revenue and Growth Rate Forecast (2017-2022)
Table China Polypeptide Drug Production, Import, Export and Consumption Forecast (2017-2022)
Table China Polypeptide Drug Production Forecast by Type (2017-2022)
Table China Polypeptide Drug Consumption Forecast by Application (2017-2022)


More Publications